Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis

Muscle & Nerve
Jeffrey A AllenH Royden Jones

Abstract

The objectives of this study were (I) to explore the prognosis of ocular myasthenia gravis (OMG) in patients with onset at age 70 years and above (i.e. senior persons); (2) to identify predictors of secondary generalization in this age group; and 3) to address the effects of immunotherapy on this population of patients. We performed a retrospective analysis of 39 patients with myasthenia gravis who presented with only ocular signs and symptoms after age 70 years. Generalized myasthenia gravis (GMG) developed in 12 OMG patients (31%). None of the GMG patients required ventilator assistance or a feeding tube. Of the 12 ocular patients progressing to GMG, only one (8%) received immunotherapy prior to generalization. Of those OMG patients who did not progress to GMG, 52% received immunomodulatory therapy. Our senior OMG patients had a prognosis comparable with those of the published data for younger individuals. Although the presence of increased acetylceholine receptor antibody titers and occasionally abnormal repetitive nerve stimulation were useful tools to diagnose OMG, no test was predictive of later generalization. Senior onset OMG patients who received immunotherapy less frequently developed GMG than those not so treated.

References

Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·I KaplanH M Blau
Oct 1, 1990·Journal of Neurology·R MantegazzaP Tonali
May 1, 1990·Neurology·D H DonaldsonS P Ringel
Oct 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·H J Oosterhuis
Jan 1, 1987·Annals of the New York Academy of Sciences·D GrobT Namba
Nov 1, 1983·Annals of Neurology·C T BeverL P Rowland
Sep 1, 1993·Neurology·P B ChristensenB de Fine Olivarius
Apr 1, 1996·Acta Neurologica Scandinavica·G AntoniniM Fiorelli
Feb 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·N SommerJ Dichgans
Feb 1, 1997·Journal of Neurology·R BeekmanH J Oosterhuis
Jul 21, 1998·Annals of the New York Academy of Sciences·G SlesakJ Dichgans
Oct 15, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·N P RobertsonD A Compston
Aug 24, 1999·Muscle & Nerve·D H WeinbergJ J Kelly
Nov 18, 2000·Journal of the American Geriatrics Society·A EvoliP Tonali
Mar 3, 2001·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·J S WeizerD K Coats
Feb 13, 2003·Archives of Neurology·Mark J KupersmithPeter Homel
Mar 26, 2003·Neurology·J M AragonèsI Illa
Jul 19, 2003·Seminars in Neurology·Robert M Pascuzzi
Nov 1, 2003·Annals of the New York Academy of Sciences·Renato MantegazzaFerdinando Cornelio
Dec 10, 2003·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Jared MeeJustin O'Day
Jan 7, 2004·Journal of the Neurological Sciences·Nicholas T MonsulJonathan M Goldstein
Mar 30, 2004·Annals of Neurology·John McConvilleAngela Vincent
Apr 27, 2007·Neurology·Michael BenatarUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology
Oct 22, 2008·Neurology·Minal J BhanushaliMichael Benatar

❮ Previous
Next ❯

Citations

Apr 4, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M GattellariJ M Worthington
Jul 6, 2014·BMC Neurology·Shigeaki SuzukiKimiaki Utsugisawa
Nov 16, 2013·The International Journal of Neuroscience·Alessandra AriattiGiuliana Galassi
May 26, 2015·Journal of Neuroimmunology·Da-Qi ZhangLi Yang
Jan 3, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H ZachF Zimprich
Apr 22, 2015·Ophthalmology·Lina NagiaEric R Eggenberger
Jul 15, 2011·Muscle & Nerve·Jose C RocheRaquel Alarcia
Aug 24, 2013·Muscle & Nerve·Shi Hui WongSandra G Brauer
Jul 30, 2014·Acta Neurologica Scandinavica·S HoffmannA Meisel
Feb 26, 2011·Korean Journal of Ophthalmology : KJO·Hyun Seok RohJin Sook Yoon
Sep 23, 2016·Journal of the Neurological Sciences·Lauren Gotterer, Yuebing Li
Jun 20, 2017·The International Journal of Neuroscience·Marco MazzoliGiuliana Galassi
Feb 13, 2018·European Neurology·Florencia Aguirre, Andres M Villa
Mar 15, 2018·Frontiers in Neurology·Xin HuangWeibin Liu
Sep 19, 2018·Journal of Neurology·Feng LiJens-C Rückert
Apr 20, 2017·BMC Neurology·Lili WangMaolin He
Jun 3, 2018·Acta neurologica Belgica·Giuliana GalassiPaolo F Nichelli
Jan 14, 2021·Acta neurologica Belgica·Onur Akan, Leyla Baysal-Kirac
Jan 7, 2020·Journal of the Neurological Sciences·John Morren, Yuebing Li
Jun 10, 2021·Medicine·Juthamat WitthayaweerasakNipat Aui-Aree
Oct 16, 2010·Current Opinion in Ophthalmology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the Neurological Sciences
Yoon-Ho HongKorean Research Group for Neuromuscular Diseases
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
H ZachF Zimprich
Journal of the Neurological Sciences
Nicholas T MonsulJonathan M Goldstein
© 2022 Meta ULC. All rights reserved